IXJ.ASX
Ishares Global Healthcare ETF
https://www.marketindex.com.au/asx/ixj/financials
Annual Financial Summary
Print Financials
06/2022
06/2021
06/2020
06/2019
03/2018
N/A
03/2016
03/2015
03/2014
03/2013
Profitability
NPAT ($)
72,458,000
97,795,000
-
NPAT Margin
--
--
-
Abnormals ($)
-
-
-
NPAT before Abnormals ($)
72,458,000
97,795,000
-
Return on Equity (ROE)
6.42%
10.57%
-
Return on Assets (ROA)
6.42%
10.57%
-
Valuation
PE Ratio
15.49
9.48
-
PE Relative to Market
93.0%
73.0%
-
Price to Book
0.99
1.00
-
Price to Cash Flow
22.13
13.54
-
Shares Outstanding (M)
9.54
8.33
-
Market Cap ($M)
$1,122.64
$926.80
-
Enterprise Value ($M)
$1,122.20
$926.80
-
Performance
Total Shareholder Return
6.9%
13.2%
-
Relative to Market
14.3%
-17.1%
-
Per Share
Earnings (EPS Adjusted)
759.60
1,174.43
-
Earnings (with Abnormals)
759.60
1,174.43
-
Cash Flow
(1,371.30)
(1,406.40)
-
Cash
0.05
0.00
-
Net Tangible Assets
118.32
111.07
-
Book Value
118.32
111.07
-
Share Price
$117.69
$111.30
-
Liquidity
Quick Ratio
49.94
462,431.50
-
Current Ratio
49.94
462,431.50
-
Efficiency
Asset Turnover
0.00
0.00
-
Inventory Turnover
-
-
-
Working Capital Turnover
0.00
0.00
-
Dividends
DPS (c)
140.80
119.69
-
Dividend yield
1.20%
1.08%
-
Franking
-
-
-
Gross DPS (c)
140.80
119.69
-
Gross Dividend Yield
1.20%
1.08%
-
Payout Ratio
19%
10%
-
Member Content
Source:
Annual Financial Income Statement
Print Financials
06/2022
06/2021
06/2020
06/2019
03/2018
N/A
03/2016
03/2015
03/2014
03/2013
Revenue from Operations
Investment Income
11,438,000
8,798,000
-
Other Income
61,043,000
89,014,000
-
Expenses
(23,000)
(17,000)
-
Profit / Loss before income tax
72,458,000
97,795,000
-
Tax Expense
-
-
-
NPAT before Abnormals
72,458,000
97,795,000
-
Abnormals
-
-
-
Abnormals Tax
-
-
-
Net Abnormals
-
-
-
Outside Equity
-
-
-
Preference Dividends
-
-
-
Reported NPAT after Abnormals
72,458,000
97,795,000
-
EQUITY
Share End
9,539,000
8,327,000
-
Share Weighted
9,539,000
8,327,000
-
Ordinary Dividends
(11,217,000)
-
-
EPS Adjusted
7,596,000
11,744,300
-
EPS after Abs
7,595,974
11,744,326
-
Equity Profit / Loss
-
-
-
Member Content
Source:
Annual Financial Balance Sheet
Print Financials
06/2022
06/2021
06/2020
06/2019
03/2018
N/A
03/2016
03/2015
03/2014
03/2013
CURRENT ASSETS
Cash and Cash Equivalents
0.45
-
-
Receivables
7.24
924.86
-
Investments
-
-
-
Other Current Assets
-
-
-
Total Current Assets
7.69
924.86
-
NON-CURRENT ASSETS
Investments
1,121.14
-
-
Property
-
-
-
Other Non-Current Assets
-
-
-
Total Non-Current Assets
1,121.14
-
-
TOTAL ASSETS
1,128.83
924.86
-
CURRENT LIABILITIES
Creditors
0.15
-
-
Provisions
-
-
-
Other Liabilities
-
-
-
TOTAL CURRENT LIABILITIES
0.15
-
-
NON-CURRENT LIABILITIES
Borrowings
-
-
-
Deferred Tax
-
-
-
Other Non-Current Liabilities
-
-
-
TOTAL NON-CURRENT LIABILITIES
-
-
-
TOTAL LIABILITIES
0.15
-
-
NET ASSETS
1,128.98
924.86
-
Total Equity Attr. to Holders
1,128.68
924.86
-
Outside Equity
-
-
-
TOTAL EQUITY
1,128.68
924.86
-
Member Content
Source:
Annual Financial Cash Flow
Print Financials
06/2022
06/2021
06/2020
06/2019
03/2018
N/A
03/2016
03/2015
03/2014
03/2013
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
11.71
-
-
Payments
(154.09)
(117.11)
-
Funds from Operations
-
-
-
Dividends Received
11.58
-
-
Interest Received
-
-
-
Interest Paid
-
-
-
Tax Paid
-
-
-
Other Operating Cash
(0.01)
-
-
NET CASH FROM OPERATING ACTIVITIES
(130.81)
(117.11)
-
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
-
-
-
Payments
-
-
-
PP&E
-
-
-
Proceeds PP&E
-
-
-
Purchase Subsidiary
-
-
-
Proceeds Subsidiary
-
-
-
Loans Granted
-
-
-
Loans Repaid
-
-
-
Other Investing Cash
-
-
-
NET CASH FROM INVESTING ACTIVITIES
-
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
147.86
136.76
-
Proceeds from Borrowings
-
-
-
Borrowings
-
-
-
Dividends Paid
(10.61)
(9.72)
-
Other Financing Cash
(6.04)
(10.46)
-
NET CASH FROM FINANCING ACTIVITIES
131.21
116.58
-
NET CHANGE IN CASH
0.4
(0.53)
-
CASH AT START
0.13
0.43
-
Exchange Rate Adjustment
(0.08)
0.22
-
Other Cash Adjustment
-
-
-
CASH AT END
0.45
0.13
-
Member Content
Source: